Nicola Longley

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

N. Freemantle, A. Agyeman, N. Longley, 2022, medRxiv.